Giroletti Laura, Graniero Ascanio, Agnino Alfonso
Department of Cardiovascular Surgery, Division of Robotic and Minimally-Invasive Cardiac Surgery, Humanitas Gavazzeni-Castelli, 24125 Bergamo, Italy.
J Clin Med. 2024 Apr 22;13(8):2435. doi: 10.3390/jcm13082435.
In recent years, there has been a growing interest in robotic-assisted coronary artery revascularization in Europe. Two different types of surgery can be performed using a robotic platform: RA-MIDCAB, in which the mammary artery is harvested endoscopically with robotic assistance and off-pump bypass graft is achieved under direct vision through mini thoracotomy, and TE-CAB, completely robotically performed. We started the robotic cardiac surgery program for mitral valve disease in our hospital, Humanitas Gavazzeni (Bergamo, Italy), in 2019; and in 2021, we addressed our experience with RA-MIDCAB. After a learning curve period, we have developed our technique to optimize the benefits offered by the robotic platform, tailoring strategy to individual patients, based on preoperative radiological images.
近年来,欧洲对机器人辅助冠状动脉血运重建的兴趣日益浓厚。使用机器人平台可进行两种不同类型的手术:RA-MIDCAB(机器人辅助微创直接冠状动脉旁路移植术),即在机器人辅助下通过内镜获取乳内动脉,并通过迷你开胸术在直视下完成非体外循环搭桥移植;以及TE-CAB(全机器人冠状动脉旁路移植术),完全由机器人操作。我们于2019年在我院(意大利贝加莫的加瓦泽尼人道主义医院)启动了针对二尖瓣疾病的机器人心脏手术项目;2021年,我们介绍了我们在RA-MIDCAB方面的经验。经过学习曲线阶段后,我们改进了技术,以优化机器人平台带来的益处,并根据术前放射影像为个体患者量身定制策略。